As of Q4'25, Johnson & Johnson ( JNJ ) reported net income of $5.1B, maintaining a stable level compared to the previous quarters. The year-over-year ( YoY ) growth rate for this period was 49.1%, indicating a significant improvement from the prior year. From Q1'23 to Q4'25, JNJ's net income showed considerable volatility, with a notable loss of $68M in Q1'23 followed by a sharp rebound to $26B in Q3'23, likely reflecting one-off items or extraordinary gains. After this peak, net income normalized, fluctuating between $2.7B and $5.5B per quarter, except for another spike to $11B in Q1'25. YoY growth rates were highly variable, with extreme swings—such as a 4.8x increase in Q3'23 and a 48.9% surge in Q1'24—followed by periods of negative or modest growth, suggesting underlying earnings volatility and potential non-recurring impacts during the observed period. The chart covers quarterly data from Q1'23 to Q4'25.